Advancing Clinical Evidence in Infectious Diseases: An Infectious Diseases Clinical Trials Network for Asia, the “Antimicrobial Resistance Hot Zone”
Clinical Infectious Diseases · 02.06.2026 · 82 (Supplement_5) · S101-S104
DOI: 10.1093/cid/ciag122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 02.06.2026. Verfasst von David L Paterson. Beteiligte Einrichtung: ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, SINGAPORE. Hauptthemen laut MEDLINE: Communicable Diseases, Anti-Bacterial Agents, Drug Resistance, Bacterial, Clinical Trials as Topic. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
ADVANCE-ID (ADVancing Clinical Evidence in Infectious Diseases) is a clinical trials network comprising more than 100 hospitals across Asia, with additional research sites planned for Africa, the Middle East, and Latin America. The mission of ADVANCE-ID is to conduct high-quality clinical trials that have a global impact on the management of infection. More than 12 000 patients have been enrolled since 2022 in ADVANCE-ID studies. A key aim of ADVANCE-ID is to create evidence from randomized controlled trials to improve treatment, diagnostics, and prevention strategies of serious infections resulting from antimicrobial-resistant bacterial infections. Alongside this, ADVANCE-ID has a commitment to advocate for access to antibiotics and diagnostics for which evidence exists for their use in low- and middle-income countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, SINGAPORE.
- Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SINGAPORE.
ORCID-Profile: David L Paterson
Zitieren
APA
Paterson, D. L. (2026). Advancing Clinical Evidence in Infectious Diseases: An Infectious Diseases Clinical Trials Network for Asia, the “Antimicrobial Resistance Hot Zone”. Clinical Infectious Diseases, 82(Supplement_5), S101-S104. https://doi.org/10.1093/cid/ciag122
Vancouver
Paterson DL. Advancing Clinical Evidence in Infectious Diseases: An Infectious Diseases Clinical Trials Network for Asia, the “Antimicrobial Resistance Hot Zone”. Clinical Infectious Diseases. 2026;82(Supplement_5):S101-S104. doi:10.1093/cid/ciag122
BibTeX
@article{Paterson2026,
author = {Paterson, David L},
title = {Advancing Clinical Evidence in Infectious Diseases: An Infectious Diseases Clinical Trials Network for Asia, the “Antimicrobial Resistance Hot Zone”},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {82},
number = {Supplement_5},
pages = {S101--S104},
doi = {10.1093/cid/ciag122}
}
EUVIMED